Department of Cardiothoracic Surgery, Liverpool Heart and Chest, Liverpool, UK.
School of Medicine, University of Liverpool, Liverpool, UK.
Heart Lung Circ. 2020 Jan;29(1):49-61. doi: 10.1016/j.hlc.2019.05.170. Epub 2019 May 31.
It has been over two decades since the very first robotic cardiac surgery was performed. Over the years, there has been an increase in the demand for less invasive cardiac surgical techniques. Developments in technology and engineering have provided an opportunity for robotic surgery to be applied to a variety of cardiac procedures, including coronary revascularisation, mitral valve surgery, atrial fibrillation ablation, and others. In coronary revascularisation, it is becoming more widely used in single vessel, as well as hybrid coronary artery approaches. Currently, several international centres are specialising in a totally endoscopic coronary artery bypass surgery involving multiple vessels. Mitral valve and other intracardiac pathologies such as atrial septal defect and intracardiac tumour are also increasingly being addressed robotically. Even though some studies have shown good results with robot-assisted cardiac surgery, there are still concerns about safety, cost and clinical efficacy. There are also limitations and additional challenges with the management of cardiopulmonary bypass and myocardial protection during robotic surgery. Implementing novel strategies to manage these challenges, together with careful patient selection can go a long way to producing satisfactory results. This review examines the current evidence behind robotic surgery in various aspects of cardiac surgery.
自首例机器人心脏手术开展以来,已经过去了二十多年。多年来,人们对微创心脏外科技术的需求不断增加。技术和工程的发展为机器人手术应用于各种心脏手术提供了机会,包括冠状动脉血运重建术、二尖瓣手术、房颤消融术等。在冠状动脉血运重建术中,它在单支血管以及杂交冠状动脉方法中应用越来越广泛。目前,一些国际中心正在专门从事涉及多支血管的完全内窥镜冠状动脉旁路移植术。二尖瓣和其他心内病变,如房间隔缺损和心内肿瘤,也越来越多地采用机器人技术治疗。尽管一些研究表明机器人辅助心脏手术有良好的效果,但仍存在对安全性、成本和临床疗效的担忧。机器人手术中体外循环和心肌保护的管理也存在局限性和额外的挑战。实施新的策略来管理这些挑战,并结合仔细的患者选择,可以取得令人满意的效果。这篇综述检查了机器人手术在心脏外科各个方面的现有证据。